CDCD25: A Potential Drug Target and Biomarker for Brain Health and Function

Target Name: CCDC25

NCBI ID: G55246

CCDC25

CDCD25: A Potential Drug Target and Biomarker for Brain Health and Function

CCDC25 (Flj10853) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its function is not well understood, but it is known to be involved in the regulation of cellular processes that are important for maintaining tissue health and function.

One of the things that makes CCDC25 an interesting potential drug target is its location in the brain. The brain is a complex and dynamic system that is responsible for controlling and coordinating all of the body's functions, and it is home to a large number of drug targets. Many of these targets are involved in the regulation of signaling pathways that are important for brain development, growth, and function, and they are often implicated in a wide range of neurological and psychiatric disorders.

CDC25 is thought to be involved in the regulation of several different signaling pathways that are important for brain development and function. For example, it has been shown to be involved in the regulation of the Wnt signaling pathway, a pathway that is important for the development and maintenance of tissues in the brain. Wnt signaling is a complex signaling pathway that is involved in the regulation of cell proliferation, differentiation, and survival, and it is thought to play an important role in the development of many neurological disorders, including cancer, neurodegenerative diseases, and developmental disorders.

Another signaling pathway that is thought to be regulated by CCDC25 is theNotch signaling pathway. Notch signaling is a signaling pathway that is involved in the regulation of cell proliferation, differentiation, and survival, and it is thought to play an important role in the development and maintenance of tissues in the brain. CCDC25 has been shown to be involved in the regulation of Notch signaling, and its function in this pathway is not well understood.

In addition to its role in regulating these signaling pathways, CCDC25 is also thought to be involved in the regulation of several other cellular processes that are important for brain health and function. For example, it is known to be involved in the regulation of the blood-brain barrier, which is a barrier that separates the brain from the blood and helps to protect it from harmful substances. The blood-brain barrier is also thought to be involved in the regulation of brain shipping, which is the movement of nutrients and waste products into and out of the brain.

Given the complexity and importance of CCDC25 in the regulation of cellular processes that are important for brain health and function, it is not surprising that it is a potential drug target. Many drugs that are currently in use are designed to target CCDC25 and to modulate its function. These drugs include compounds that inhibit the activity of CCDC25, as well as those that enhance its activity.

The potential targets for CCDC25 are wide and varied. Some studies have suggested that CCDC25 may be a potential target for drugs that are used to treat a wide range of psychiatric and neurological disorders, including depression, anxiety, and schizophrenia. Other studies have suggested that CCDC25 may be a potential target for drugs that are used to treat neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

In addition to its potential therapeutic uses, CCDC25 is also an interesting potential biomarker for a number of diseases. Because it is expressed in a variety of tissues and is involved in the regulation of cellular processes that are important for brain health and function, it may be a useful marker for the diagnosis and treatment of a wide range of neurological and psychiatric disorders.

Overall, CCDC25 is a protein that is expressed in various tissues of the body and is involved in the regulation of cellular processes that are important for brain health and function. Its function is not well understood, but it is known to be involved in the regulation of several different signaling pathways that are important for brain development and function. As a potential drug target and biomarker, CCDC25 is a promising target for the development of new therapies for a wide range of psychiatric and neurological disorders.

Protein Name: Coiled-coil Domain Containing 25

Functions: Transmembrane receptor that senses neutrophil extracellular traps (NETs) and triggers the ILK-PARVB pathway to enhance cell motility (PubMed:32528174). NETs are mainly composed of DNA fibers and are released by neutrophils to bind pathogens during inflammation (PubMed:32528174). Formation of NETs is also associated with cancer metastasis, NET-DNA acting as a chemotactic factor to attract cancer cells (PubMed:32528174). Specifically binds NETs on its extracellular region, in particular the 8-OHdG-enriched DNA present in NETs, and recruits ILK, initiating the ILK-PARVB cascade to induce cytoskeleton rearrangement and directional migration of cells (PubMed:32528174). In the context of cancer, promotes cancer metastasis by sensing NETs and promoting migration of tumor cells (PubMed:32528174)

The "CCDC25 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CCDC25 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets